Biofil Chemicals & Pharmaceuticals Ltd. (IN:BIOFILCHEM)
:BIOFILCHEM
Want to see IN:BIOFILCHEM full AI Analyst Report?
Total Valuation
Biofil Chemicals & Pharmaceuticals Ltd. has a market cap or net worth of ₹578.21M. The enterprise value is ₹578.40M.
Market Cap₹578.21M
Enterprise Value₹578.40M
Share Statistics
Biofil Chemicals & Pharmaceuticals Ltd. has 16,273,800 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding16,273,800
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Biofil Chemicals & Pharmaceuticals Ltd.’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 1.21%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)1.21%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee10.92M
Profits Per Employee1.07M
Employee Count26
Asset Turnover0.66
Inventory Turnover6.18
Valuation Ratios
The current PE Ratio of Biofil Chemicals & Pharmaceuticals Ltd. is 20.7. Biofil Chemicals & Pharmaceuticals Ltd.’s PEG ratio is 0.04.
PE Ratio20.7
PS Ratio1.48
PB Ratio1.95
Price to Fair Value1.95
Price to FCF-51.52
Price to Operating Cash Flow-16.18
PEG Ratio0.04
Income Statement
In the last 12 months, Biofil Chemicals & Pharmaceuticals Ltd. had revenue of 283.95M and earned 27.86M in profits. Earnings per share was 1.71.
Revenue283.95M
Gross Profit10.37M
Operating Income3.77M
Pretax Income34.50M
Net Income27.86M
EBITDA6.49M
Earnings Per Share (EPS)1.71
Cash Flow
In the last 12 months, operating cash flow was -35.65M and capital expenditures -705.00K, giving a free cash flow of -36.36M billion.
Operating Cash Flow-35.65M
Free Cash Flow-36.36M
Free Cash Flow per Share-2.23
Dividends & Yields
Biofil Chemicals & Pharmaceuticals Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.63
52-Week Price Change-23.62%
50-Day Moving Average34.19
200-Day Moving Average35.73
Relative Strength Index (RSI)54.84
Average Volume (3m)6.87K
Important Dates
Biofil Chemicals & Pharmaceuticals Ltd. upcoming earnings date is Aug 18, 2026, TBA (Confirmed).
Last Earnings DateMay 30, 2026
Next Earnings DateAug 18, 2026
Ex-Dividend Date―
Financial Position
Biofil Chemicals & Pharmaceuticals Ltd. as a current ratio of 1.73, with Debt / Equity ratio of 14.00%
Current Ratio1.73
Quick Ratio1.52
Debt to Market Cap0.07
Net Debt to EBITDA-0.47
Interest Coverage Ratio37.37
Taxes
In the past 12 months, Biofil Chemicals & Pharmaceuticals Ltd. has paid 6.64M in taxes.
Income Tax6.64M
Effective Tax Rate0.19
Enterprise Valuation
Biofil Chemicals & Pharmaceuticals Ltd. EV to EBITDA ratio is 64.23, with an EV/FCF ratio of -51.15.
EV to Sales1.47
EV to EBITDA64.23
EV to Free Cash Flow-51.15
EV to Operating Cash Flow-67.82
Balance Sheet
Biofil Chemicals & Pharmaceuticals Ltd. has ₹3.59M in cash and marketable securities with ₹200.00K in debt, giving a net cash position of ₹3.39M billion.
Cash & Marketable Securities₹3.59M
Total Debt₹200.00K
Net Cash₹3.39M
Net Cash Per Share₹0.21
Tangible Book Value Per Share₹13.24
Margins
Gross margin is 5.70%, with operating margin of 1.33%, and net profit margin of 9.81%.
Gross Margin5.70%
Operating Margin1.33%
Pretax Margin12.15%
Net Profit Margin9.81%
EBITDA Margin2.29%
EBIT Margin1.33%
Analyst Forecast
The average price target for Biofil Chemicals & Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-14.99%
EPS Growth Forecast399.30%